Background:Angiotensin-converting enzyme 2 has been identified as the receptor that allows the entry of SarsCov2 into the human cell. Its expression in the kidney is 100 times higher than in the lung; thus, making the kidney an excellent target for SarsCov2 infection manifesting as renal failure (RF). The objective of this study was to determine the predictive factors of RF during COVID-19 in the Togolese context. PatientsandMethods:This was a retrospective descriptive and analytical study conducted at the Lomé Anti-COVID Center including the records of patients hospitalized for COVID-19, of age ≥ 18 years and having performed a creatinemia. RF was defined by a GFR < 60 ml/min/1.73m2 calculated according to the MDRD formula. Patients were randomized into 2 groups according to GFR<60 or not. Statistical tests used were Pearson’s Chi-2 test or Fisher’s exact test for qualitative variables and Mann-Whitney test or Wilcoxon test for quantitative variables. The significance level was set at 0.05. Univariate and multivariate logistic regression was performed to search for associated factors. Results: 482 patients were selected for this study with a mean age of 58.02 years. Sixty-five percent of the patients were men, i.e., a sex ratio of 1.88. Fifty-two patients had RF, i.e., a frequency of 10.8%.There were 65% men (315 cases), for a sex ratio (M/F) of 1.88. Risk factors for renal failure in COVID-19 were age ≥ 65 years (ORa 2.42; CIa95% [1.17 - 4.95]; p = 0.016), anemia (ORa 2.49; CIa95% [1.21 - 5.26]; p = 0.015), moderate (ORa 13; CIa95% [2.30 - 2.44]; p = 0.017), severe (ORa 26.2; CIa95% [4.85 - 4.93]; p = 0.002) and critical (ORa 108; CIa95% [16.5 - 21.76]; p < 0.001) severity stages at admission. Conclusion: Renal failure would therefore be related to the severity of COVID-19 and is the most formidable factor, conditioning the course of the disease and the patient’s vital prognosis.
References
[1]
Lu, H., Stratton, C.W. and Tang, Y.-W. (2020) Outbreak of Pneumonia of Unknown Etiology in Wuhan, China: The Mystery and the Miracle. Journal of Medical Virology, 92, 401-402. https://doi.org/10.1002/jmv.25678
[2]
Al-Dmour, H., Masa’deh, R., Salman, A., Abuhashesh, M. and Al-Dmour, R. (2020) Influence of Social Media Platforms on Public Health Protection against the COVID-19 Pandemic via the Mediating Effects of Public Health Awareness and Behavioral Changes: Integrated Model. Journal of Medical Internet Research, 22, Article ID: 19996. https://doi.org/10.2196/19996
[3]
Guan, W., Ni, Z., Hu, Y., Hu, Y., Liang, W., Ou, C.,etal. (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. The New England Journal of Medicine, 382, 1708-1720. https://doi.org/10.1056/NEJMoa2002032
[4]
Zhou, P., Yang, X., Wang, X., Hu, B., Zhang, L., Zhang, W., etal. (2020) A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature, 579, 270-273. https://doi.org/10.1038/s41586-020-2012-7
[5]
Li, W., Moore, M.J., Vasilieva, N., Sui, J., Wong, S.K., Berne, M.A., etal. (2003) Angiotensin-Converting Enzyme 2 is a Functional Receptor for the SARS Coronavirus. Nature, 426, 450-454. https://doi.org/10.1038/nature02145
[6]
Guedon, J., Gontard, F., Durand, M., Gay, M. and Delamare, J. (1969) Renal Functions in Cyanogenic Congenital Cardiopathies. Study of Clearances and of Concentration-Dilution Ability. Journal of Urology and Nephrology(Paris), 75, 319-325.
[7]
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., etal. (2020) Clinical Course and Outcomes of Critically Ill Patients with SARS-CoV-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective, Observational Study. The Lancet Respiratory Medicine, 8, 475-481. https://doi.org/10.1016/S2213-2600(20)30079-5
[8]
See, Y.P., Young, B.E., Ang, L.W., Ooi, X.Y., Chan, C.P., Looi, W.L., etal. (2021) Risk Factors for Development of Acute Kidney Injury in COVID-19 Patients: A Retrospective Observational Cohort Study. Nephron, 145, 256-264. https://doi.org/10.1159/000514064
[9]
Lin, L., Wang, X., Ren, J., Sun, Y., Yu, R., Zheng, L., etal. (2020) Risk Factors and Prognosis for COVID-19-Induced Acute Kidney Injury: A Meta-Analysis. BMJOpen, 10, Article ID: 042573. https://doi.org/10.1136/bmjopen-2020-042573
[10]
Stoecklin, S.B., Rolland, P., Silue, Y., Mailles, A., Campese, C., Simondon, A., etal. (2020) First Cases of Coronavirus Disease 2019 (COVID-19) in France: Surveillance, Investigations and Control Measures. Eurosurveillance, 25, Article ID: 2000094. https://doi.org/10.2807/1560-7917.ES.2020.25.6.2000094
[11]
Sohrabi, C., Alsafi, Z., O’Neill, N., Khan, M., Kerwan, A., Al-Jabir, A., etal. (2020) World Health Organization Declares Global Emergency: A Review of the 2019 Novel Coronavirus (COVID-19). International Journal of Surgery, 76, 71-76. https://doi.org/10.1016/j.ijsu.2020.02.034
[12]
Wu, Z. and McGoogan, J.M. (2020) Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention. JAMA, 323, 1239-1242. https://doi.org/10.1001/jama.2020.2648
[13]
Sang, L., Chen, S., Zheng, X., Guan, W., Zhang, Z., Liang, W., etal. (2020) The Incidence, Risk Factors and Prognosis of Acute Kidney Injury in Severe and Critically Ill Patients with COVID-19 in Mainland China: A Retrospective Study. BMC Pulmonary Medicine, 20, 290. https://doi.org/10.1186/s12890-020-01305-5
[14]
Appel, R.G., Bleyer, A.J., Reavis, S. and Hansen, K.J. (1995) Renovascular Disease in Older Patients Beginning Renal Replacement Therapy. Kidney International, 48, 171-176. https://doi.org/10.1038/ki.1995.281
[15]
Beurton, A., Haudebourg, L., Simon-Tillaux, N., Demoule, A. and Dres, M. (2020) Limiting Positive End-Expiratory Pressure to Protect Renal Function in SARS-CoV-2 Critically Ill Patients. Journal of Critical Care, 59, 191-193. https://doi.org/10.1016/j.jcrc.2020.07.008
[16]
Cheng, Y., Luo, R., Wang, X., Wang, K., Zhang, N., Zhang, M., etal. (2020) The Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Adult Patients with Coronavirus Disease 2019. Clinical Journal of the American Society of Nephrology, 15, 1394-1402. https://doi.org/10.2215/CJN.04650420
Henry, B.M., de Oliveira, M.H.S., Benoit, S., Plebani, M. and Lippi, G. (2020) Hematologic, Biochemical and Immune Biomarker Abnormalities Associated with Severe Illness and Mortality in Coronavirus Disease 2019 (COVID-19): A Meta-Analysis. Clinical Chemistry and Laboratory Medicine, 58, 1021-1028. https://doi.org/10.1515/cclm-2020-0369
[19]
Madu, A.J. and Ughasoro, M.D. (2017) Anaemia of Chronic Disease: An In-Depth Review. Medical Principles and Practice, 26, 1-9. https://doi.org/10.1159/000452104